Abstract
Cloning and characterization of the ghrelin receptor as a 7-transmembrane (7TM), G-protein-coupled receptor (GPCR) was first reported by Howard and his co-workers (1996). The ghrelin receptor was initially described as a growth hormone secretagogue receptor since (GHSR) this was the most well-established physiological function at that time. The natural endogenous agonist remained unknown until Kojima and his co-workers discovered (1999) the peptide hormone ghrelin. Afterward, the activity of ghrelin receptors was linked primarily with the regulation of appetite, adiposity, and energy expenditure as well as inducing of growth hormone secretion (Davenport et al. 2005; Kojima et al. 2001). Another important milestone in the pharmacological characterization of the ghrelin receptor was the discovery of its constitutive activity (Holst et al. 2003, 2004). This chapter will focus on the molecular basis of this phenomenon and its relevance in health and disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abizaid A, Liu ZW, Andrews ZB et al (2006) Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest 116(12):3229â3239
Adan RA (2006) Constitutive receptor activity series: endogenous inverse agonists and constitutive receptor activity in the melanocortin system. Trends Pharmacol Sci 27(4):183â186
Arvanitakis L, Geras-Raaka E, Gershengorn MC (1998) Constitutively signaling G-protein-coupled receptors and human disease. Trends Endocrinol Metab 9(1):27â31
Bakker RA, Jongejan A, Sansuk K et al (2008) Constitutively active mutants of the histamine H1 receptor suggest a conserved hydrophobic asparagine-cage that constrains the activation of class A G protein-coupled receptors. Mol Pharmacol 73(1):94â103
Berson EL (1993) Retinitis pigmentosa. The friedenwald lecture. Invest Ophthalmol Vis Sci 34(5):1659â1676
Case R, Sharp E, Benned-Jensen T et al (2008) Functional analysis of the murine cytomegalovirus chemokine receptor homologue M33: ablation of constitutive signaling is associated with an attenuated phenotype in vivo. J Virol 82(4):1884â1898
Chow KB, Leung PK, Cheng CH et al (2008) The constitutive activity of ghrelin receptors is decreased by co-expression with vasoactive prostanoid receptors when over-expressed in human embryonic kidney 293 cells. Int J Biochem Cell Biol 40(11):2627â2637
Corvilain B, Van SJ, Dumont JE et al (2001) Somatic and germline mutations of the TSH receptor and thyroid diseases. Clin Endocrinol (Oxf) 55(2):143â158
Costa T, Cotecchia S (2005) Historical review: negative efficacy and the constitutive activity of G-protein-coupled receptors. Trends Pharmacol Sci 26(12):618â624
Daiger SP, Sullivan LS, Bowne SJ (2013) Genes and mutations causing retinitis pigmentosa. Clin Genet 84(2):132â141
Davenport AP, Bonner TI, Foord SM et al (2005) International union of pharmacology. LVI. Ghrelin receptor nomenclature, distribution, and function. Pharmacol Rev 57(4):541â546
De LA, Stadel JM, Lefkowitz RJ (1980) A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J Biol Chem 255(15):7108â7117
Deupi X, Kobilka BK (2010) Energy landscapes as a tool to integrate GPCR structure, dynamics, and function. Physiology (Bethesda) 25(5):293â303
Diano S, Farr SA, Benoit SC et al (2006) Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci 9(3):381â388
Elling CE, Frimurer TM, Gerlach LO et al (2006) Metal ion site engineering indicates a global toggle switch model for seven-transmembrane receptor activation. J Biol Chem 281(25):17337â17346
Gether U, Ballesteros JA, Seifert R et al (1997) Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility. J Biol Chem 272(5):2587â2590
Gjesing AP, Larsen LH, Torekov SS et al (2010) Family and population-based studies of variation within the ghrelin receptor locus in relation to measures of obesity. PLoS One 5(4):e10084
Hansen BS, Raun K, Nielsen KK et al (1999) Pharmacological characterisation of a new oral GH secretagogue, NN703. Eur J Endocrinol 141(2):180â189
Holliday ND, Holst B, Rodionova EA et al (2007) Importance of constitutive activity and arrestin-independent mechanisms for intracellular trafficking of the ghrelin receptor. Mol Endocrinol 21(12):3100â3112
Holst B, Cygankiewicz A, Jensen TH et al (2003) High constitutive signaling of the ghrelin receptorâidentification of a potent inverse agonist. Mol Endocrinol 17(11):2201â2210
Holst B, Holliday ND, Bach A et al (2004) Common structural basis for constitutive activity of the ghrelin receptor family. J Biol Chem 279(51):53806â53817
Holst B, Lang M, Brandt E et al (2006) Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor. Mol Pharmacol 70(3):936â946
Holst B, Mokrosinski J, Lang M et al (2007a) Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonism and inverse agonism. J Biol Chem 282(21):15799â15811
Holst B, Nygaard R, Valentin-Hansen L et al (2010) A conserved aromatic lock for the tryptophan rotameric switch in TM-VI of seven-transmembrane receptors. J Biol Chem 285(6):3973â3985
Holst B, Egerod K, Schwartz TW (2007b) Ghrelin: structural and functional properties. In: Sibley DR et al (eds) Handbook of Contemporary Neuropharmacology, vol 3., John Wiley & Sons IncHoboken, New Jersey, pp 765â783
Howard AD, Feighner SD, Cully DF et al (1996) A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273(5277):974â977
Jaeschke H, Neumann S, Kleinau G et al (2006) An aromatic environment in the vicinity of serine 281 is a structural requirement for thyrotropin receptor function. Endocrinology 147(4):1753â1760
Jensen AS, Sparre-Ulrich AH, Davis-Poynter N et al (2012) Structural diversity in conserved regions like the DRY-Motif among viral 7TM receptors-a consequence of evolutionary pressure? Adv Virol 2012:231813
Jerlhag E, Egecioglu E, Landgren S et al (2009) Requirement of central ghrelin signaling for alcohol reward. Proc Natl Acad Sci U S A 106(27):11318â11323
Jiang H, Betancourt L, Smith RG (2006) Ghrelin amplifies dopamine signaling by cross talk involving formation of growth hormone secretagogue receptor/dopamine receptor subtype 1 heterodimers. Mol Endocrinol 20(8):1772â1785
Katritch V, Cherezov V, Stevens RC (2013) Structure-function of the G protein-coupled receptor superfamily. Annu Rev Pharmacol Toxicol 53:531â556
Kim MS, Yoon CY, Park KH et al (2003) Changes in ghrelin and ghrelin receptor expression according to feeding status. NeuroReport 14(10):1317â1320
Kjelsberg MA, Cotecchia S, Ostrowski J et al (1992) Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J Biol Chem 267(3):1430â1433
Kojima M, Hosoda H, Date Y et al (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402(6762):656â660
Kojima M, Hosoda H, Matsuo H et al (2001) Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab 12(3):118â122
Kudo M, Osuga Y, Kobilka BK et al (1996) Transmembrane regions V and VI of the human luteinizing hormone receptor are required for constitutive activation by a mutation in the third intracellular loop. J Biol Chem 271(37):22470â22478
Lau PN, Chow KB, Chan CB et al (2009) The constitutive activity of the ghrelin receptor attenuates apoptosis via a protein kinase C-dependent pathway. Mol Cell Endocrinol 299(2):232â239
Lefkowitz RJ, Cotecchia S, Samama P et al (1993) Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci 14(8):303â307
Lefkowitz RJ, Shenoy SK (2005) Transduction of receptor signals by beta-arrestins. Science 308(5721):512â517
Leung PK, Chow KB, Lau PN et al (2007) The truncated ghrelin receptor polypeptide (GHS-R1b) acts as a dominant-negative mutant of the ghrelin receptor. Cell Signal 19(5):1011â1022
Levin MC, Marullo S, Muntaner O et al (2002) The myocardium-protective Gly-49 variant of the beta 1-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation. J Biol Chem 277(34):30429â30435
Liu G, Fortin JP, Beinborn M et al (2007) Four missense mutations in the ghrelin receptor result in distinct pharmacological abnormalities. J Pharmacol Exp Ther 322(3):1036â1043
Mary S, Fehrentz JA, Damian M et al (2013) Heterodimerization with its splice variant blocks the ghrelin receptor 1a in a nonsignaling conformation. A study with a purified heterodimer assembled into lipid discs. J Biol Chem 288(34):24656â24665
Matthews RP, Guthrie CR, Wailes LM et al (1994) Calcium/calmodulin-dependent protein kinase types II and IV differentially regulate CREB-dependent gene expression. Mol Cell Biol 14(9):6107â6116
Mokrosinski J, Frimurer TM, Sivertsen B et al (2012) Modulation of constitutive activity and signaling bias of the ghrelin receptor by conformational constraint in the second extracellular loop. J Biol Chem 287(40):33488â33502
Mokrosinski J, Holst B (2010) Modulation of the constitutive activity of the ghrelin receptor by use of pharmacological tools and mutagenesis. Methods Enzymol 484:53â73
Nogueiras R, Tovar S, Mitchell SE et al (2004) Regulation of growth hormone secretagogue receptor gene expression in the arcuate nuclei of the rat by leptin and ghrelin. Diabetes 53(10):2552â2558
Nygaard R, Frimurer TM, Holst B et al (2009) Ligand binding and micro-switches in 7TM receptor structures. Trends Pharmacol Sci 30(5):249â259
Okada M, Northup JK, Ozaki N et al (2004) Modification of human 5-HT(2C) receptor function by Cys23Ser, an abundant, naturally occurring amino-acid substitution. Mol Psychiatry 9(1):55â64
Pan Z, Lu T, Zhang X et al (2012) Identification of two mutations of the RHO gene in two Chinese families with retinitis pigmentosa: correlation between genotype and phenotype. Mol Vis 18:3013â3020
Pantel J, Legendre M, Cabrol S et al (2006) Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. J Clin Invest 116(3):760â768
Perello M, Sakata I, Birnbaum S et al (2010) Ghrelin increases the rewarding value of high-fat diet in an orexin-dependent manner. Biol Psychiatry 67(9):880â886
Petersen PS, Woldbye DP, Madsen AN et al (2009) In vivo characterization of high Basal signaling from the ghrelin receptor. Endocrinology 150(11):4920â4930
Rasmussen SG, DeVree BT, Zou Y et al (2011) Crystal structure of the beta2 adrenergic receptor-Gs protein complex. Nature 477(7366):549â555
Rediger A, Piechowski CL, Habegger K et al (2012) MC4R dimerization in the paraventricular nucleus and GHSR/MC3R heterodimerization in the arcuate nucleus: is there relevance for body weight regulation? Neuroendocrinology 95(4):277â288
Rediger A, Piechowski CL, Yi CX et al (2011) Mutually opposite signal modulation by hypothalamic heterodimerization of ghrelin and melanocortin-3 receptors. J Biol Chem 286(45):39623â39631
Ren Q, Kurose H, Lefkowitz RJ et al (1993) Constitutively active mutants of the alpha 2-adrenergic receptor. J Biol Chem 268(22):16483â16487
Rivera-De la Parra D, Cabral-Macias J, Matias-Florentino M et al (2013) Rhodopsin p. N78I dominant mutation causing sectorial retinitis pigmentosa in a pedigree with intrafamilial clinical heterogeneity. Gene 519(1):173â176
Rovati GE, Capra V, Neubig RR (2007) The highly conserved DRY motif of class A G protein-coupled receptors: beyond the ground state. Mol Pharmacol 71(4):959â964
Samama P, Cotecchia S, Costa T et al (1993) A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. J Biol Chem 268(7):4625â4636
Scheerer P, Park JH, Hildebrand PW et al (2008) Crystal structure of opsin in its G-protein-interacting conformation. Nature 455(7212):497â502
Schellekens H, van Oeffelen WE, Dinan TG et al (2013) Promiscuous dimerization of the growth hormone secretagogue receptor (GHS-R1a) attenuates ghrelin-mediated signaling. J Biol Chem 288(1):181â191
Schneider EH, Schnell D, Strasser A et al (2010) Impact of the DRY motif and the missing âionic lockâ on constitutive activity and G-protein coupling of the human histamine H4 receptor. J Pharmacol Exp Ther 333(2):382â392
Schwartz TW, Frimurer TM, Holst B et al (2006) Molecular mechanism of 7TM receptor activationâa global toggle switch model. Annu Rev Pharmacol Toxicol 46:481â519
Seifert R, Wenzel-Seifert K (2002) Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch Pharmacol 366(5):381â416
Singh LP, Andy J, Anyamale V et al (2001) Hexosamine-induced fibronectin protein synthesis in mesangial cells is associated with increases in cAMP responsive element binding (CREB) phosphorylation and nuclear CREB: the involvement of protein kinases A and C. Diabetes 50(10):2355â2362
Sivertsen B, Holliday N, Madsen AN et al (2013) Functionally biased signalling properties of 7TM receptorsâopportunities for drug development for the ghrelin receptor. Br J Pharmacol 170(7):1349â1362
Sivertsen B, Lang M, Frimurer TM et al (2011) Unique interaction pattern for a functionally biased ghrelin receptor agonist. J Biol Chem 286(23):20845â20860
Smit MJ, Vischer HF, Bakker RA et al (2007) Pharmacogenomic and structural analysis of constitutive g protein-coupled receptor activity. Annu Rev Pharmacol Toxicol 47:53â87
Steen A, Thiele S, Guo D et al (2013) Biased and constitutive signaling in the CC-chemokine receptor CCR5 by manipulating the interface between transmembrane helices 6 and 7. J Biol Chem 288(18):12511â12521
Tolle V, Low MJ (2008) In vivo evidence for inverse agonism of Agouti-related peptide in the central nervous system of proopiomelanocortin-deficient mice. Diabetes 57(1):86â94
Vishnivetskiy SA, Ostermaier MK, Singhal A et al (2013) Constitutively active rhodopsin mutants causing night blindness are effectively phosphorylated by GRKs but differ in arrestin-1 binding. Cell Signal 25(11):2155â2162
White JF, Noinaj N, Shibata Y et al (2012) Structure of the agonist-bound neurotensin receptor. Nature 490(7421):508â513
Yanagawa M, Yamashita T, Shichida Y (2013) Glutamate acts as a partial inverse agonist to metabotropic glutamate receptor with a single amino acid mutation in the transmembrane domain. J Biol Chem 288(14):9593â9601
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
MokrosiĆski, J., Madsen, A.N., Holst, B. (2014). Constitutive Activity of the Ghrelin Receptor. In: Portelli, J., Smolders, I. (eds) Central Functions of the Ghrelin Receptor. The Receptors, vol 25. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0823-3_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0823-3_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-0822-6
Online ISBN: 978-1-4939-0823-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)